E. Bozkurtlar Et Al. , "FDG PET/CT Features of Polysaccharide-Based Hemostatic Agent Chronic Inflammatory Changes Can Mimic Metastatic Lesions," CLINICAL NUCLEAR MEDICINE , vol.47, no.7, 2022
Bozkurtlar, E. Et Al. 2022. FDG PET/CT Features of Polysaccharide-Based Hemostatic Agent Chronic Inflammatory Changes Can Mimic Metastatic Lesions. CLINICAL NUCLEAR MEDICINE , vol.47, no.7 .
Bozkurtlar, E., Oksuzoglu, K., Bostanci, K., Aslan, S., Kissa, T. N., Kocakaya, D., ... Ones, T.(2022). FDG PET/CT Features of Polysaccharide-Based Hemostatic Agent Chronic Inflammatory Changes Can Mimic Metastatic Lesions. CLINICAL NUCLEAR MEDICINE , vol.47, no.7.
Bozkurtlar, EMİNE Et Al. "FDG PET/CT Features of Polysaccharide-Based Hemostatic Agent Chronic Inflammatory Changes Can Mimic Metastatic Lesions," CLINICAL NUCLEAR MEDICINE , vol.47, no.7, 2022
Bozkurtlar, EMİNE Et Al. "FDG PET/CT Features of Polysaccharide-Based Hemostatic Agent Chronic Inflammatory Changes Can Mimic Metastatic Lesions." CLINICAL NUCLEAR MEDICINE , vol.47, no.7, 2022
Bozkurtlar, E. Et Al. (2022) . "FDG PET/CT Features of Polysaccharide-Based Hemostatic Agent Chronic Inflammatory Changes Can Mimic Metastatic Lesions." CLINICAL NUCLEAR MEDICINE , vol.47, no.7.
@article{article, author={EMİNE BOZKURTLAR Et Al. }, title={FDG PET/CT Features of Polysaccharide-Based Hemostatic Agent Chronic Inflammatory Changes Can Mimic Metastatic Lesions}, journal={CLINICAL NUCLEAR MEDICINE}, year=2022}